Park Ha Biological Technology Co Ltd (NASDAQ:PHH)’s traded shares stood at 0.54 million during the last session. At the close of trading, the stock’s price was $13.48, to imply an increase of 22.21% or $2.45 in intraday trading. The PHH share’s 52-week high remains $11.91, putting it 11.65% up since that peak but still an impressive 72.55% since price per share fell to its 52-week low of $3.70. The company has a valuation of $355.47M, with an average of 0.49 million shares in intraday trading volume over the past 10 days and average of 195.94K shares over the past 3 months.

Park Ha Biological Technology Co Ltd (NASDAQ:PHH) trade information

After registering a 22.21% upside in the last session, Park Ha Biological Technology Co Ltd (PHH) has traded red over the past five days. The 5-day price performance for the stock is 75.06%, and 147.34% over 30 days. With these gigs, the year-to-date price performance is 114.31%. Short interest in Park Ha Biological Technology Co Ltd (NASDAQ:PHH) saw shorts transact 5285.0 shares and set a 0.24 days time to cover.

PHH Dividends

Park Ha Biological Technology Co Ltd has its next earnings report out in April. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Park Ha Biological Technology Co Ltd (NASDAQ:PHH)’s Major holders

Park Ha Biological Technology Co Ltd insiders hold 81.71% of total outstanding shares, with institutional holders owning 0.30% of the shares at 1.66% float percentage. In total, 0.30% institutions holds shares in the company.